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Background: Numerous published studies have explored associations between anaemia and adverse
outcomes after surgery. However, there are no evidence syntheses describing the impact of preoperative
anaemia on postoperative outcomes.
Methods: A systematic review and meta-analysis of observational studies exploring associations between
preoperative anaemia and postoperative outcomes was performed. Studies investigating trauma, burns,
transplant, paediatric and obstetric populations were excluded. The primary outcome was 30-day or
in-hospital mortality. Secondary outcomes were acute kidney injury, stroke and myocardial infarction.
Predefined analyses were performed for the cardiac and non-cardiac surgery subgroups. A post hoc analysis
was undertaken to evaluate the relationship between anaemia and infection. Data are presented as odds
ratios (ORs) with 95 per cent c.i.
Results: From 8973 records, 24 eligible studies including 949 445 patients were identified. Some 371594
patients (39⋅1 per cent) were anaemic. Anaemia was associated with increased mortality (OR 2⋅90, 2⋅30 to
3⋅68; I2 =97 per cent; P<0⋅001), acute kidney injury (OR 3⋅75, 2⋅95 to 4⋅76; I2 =60 per cent; P<0⋅001)
and infection (OR 1⋅93, 1⋅17 to 3⋅18; I2 = 99 per cent; P=0⋅01). Among cardiac surgical patients, anaemia
was associated with stroke (OR 1⋅28, 1⋅06 to 1⋅55; I2 =0 per cent; P=0⋅009) but not myocardial infarction
(OR 1⋅11, 0⋅68 to 1⋅82; I2 = 13 per cent; P=0⋅67). Anaemia was associated with an increased incidence of
red cell transfusion (OR 5⋅04, 4⋅12 to 6⋅17; I2 = 96 per cent; P<0⋅001). Similar findings were observed in
the cardiac and non-cardiac subgroups.
Conclusion: Preoperative anaemia is associated with poor outcomes after surgery, although heterogene-
ity between studies was significant. It remains unclear whether anaemia is an independent risk factor for
poor outcome or simply a marker of underlying chronic disease. However, red cell transfusion is much
more frequent amongst anaemic patients.
Paper accepted 20 April 2015
Published online in Wiley Online Library (www.bjs.co.uk). DOI: 10.1002/bjs.9861
Introduction
Each year more than 230 million patients undergo surgery
worldwide1. Estimates of attributable mortality vary from
1 to 4 per cent; however, studies suggest that more than 80
per cent of deaths occur in a subgroup of high-risk surgical
patients1–4. Successfully treated complications may still be
associated with reduced long-term survival3. Epidemiolog-
ical studies suggest that patient co-morbidities, including
anaemia, are associated with increased rates of compli-
cation and death following surgery2,5. Anaemia may be
defined either as a reduced number of circulating red blood
cells as a percentage of blood volume (haematocrit), or as
a decreased concentration of circulating haemoglobin6.
The prevalence of anaemia among the general population
is approximately 20 per cent in Europe7, but is as high as
90 per cent amongst some surgical patient populations8,9.
Anaemia may be more common within the surgical
population for various reasons and can have multiple
aetiologies including haematinic deficiencies, in particular
iron deficiency, blood loss, or anaemia of chronic dis-
ease secondary to malignancy or an inflammatory state.
Guidelines on preoperative screening for anaemia may
also influence the perceived prevalence10. Observational
studies suggest an association between anaemia in the peri-
operative period and postoperative mortality. However,
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it remains uncertain whether anaemia is an independent
risk factor for poor postoperative outcome or a marker
of the severity of co-morbid disease. It is also unknown
whether the treatment of anaemia through allogeneic red
cell transfusion is associated with harm or benefit11,12.
Studies of surgical patients suggest that transfusion of even
a small volume of allogeneic red cells is associated with an
increase in postoperative mortality13.
The concept of patient blood management (PBM) has
been introduced to promote best practice in the timely
detection andmanagement of preoperative anaemia14. The
principles of PBM are optimization of the patient’s red
cell mass, minimization of blood loss during surgery and
the appropriate use of transfusion triggers15. The clini-
cal effects of various preoperative interventions are cur-
rently being investigated in randomized trials including
intravenous iron and erythropoietin. However, the most
effective methods of treating anaemia in the periopera-
tive period have yet to be defined and further research
is needed to address this uncertainty. The association
between preoperative anaemia and postoperative outcome
has been explored in various studies, but with inconsistent
results. To date, there have been no published syntheses
of the evidence to summarize the impact of this condi-
tion in surgery. A systematic review and meta-analysis of
observational studies was therefore performed to examine
the associations between preoperative anaemia and clinical
outcomes following surgery, and to evaluate the incidence
of allogeneic blood transfusion to treat anaemia.
Methods
The study protocol was published on PROSPERO, the
international prospective register of systematic reviews
(reference: CRD42014010795; http://www.crd.york.
ac.uk/PROSPERO). The search and analysis were per-
formed according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
statement16.
Search strategy
MEDLINE, Embase and the Cochrane database of
systematic reviews were searched (1946 to present), as
well as GreyNet (www.greynet.com), Web of Science
(wok.mimas.ac.uk) and citations of included articles.
Table 1 shows the search strategy used for the Cochrane
Library; this was then translated for different database
syntaxes. The full search strategy for each database is
shown in Tables S1 and S2 (supporting information).
Search results were limited to observational tri-
als in adult subjects conducted in the past 20 years.
Table 1 Cochrane Library search strategy
#1 anemia or Hb or haematocrit* or haemoglobin
#2 outcome* or death or mortality
#3 surgery or surgical or operat*
#4 #1 and #2 and #3
Non-English-language papers were included. The biblio-
graphies of evaluable studies and other selected papers were
searched manually. The literature search was conducted
by a literature search specialist.
Study selection criteria
Duplicates were removed and the remaining records
were entered into a database (Mendeley, London, UK).
The titles and abstracts of records were then screened
to select articles for full-text assessment. Full texts were
downloaded, and lead authors contacted if the article was
not available. Two authors independently determined suit-
ability for inclusion. Articles were included if: they were
observational in design, reported 30-day or in-hospital
mortality, incidence of acute kidney injury, stroke or
myocardial infarction (using the authors’ definitions) in
relation to preoperative haemoglobin levels; study subjects
were over 16 years of age; and the study had a compara-
ble non-anaemic group. Articles were excluded if study
subjects underwent burns, obstetric, trauma or transplant
surgery. Studies were assessed for methodological qual-
ity using the Newcastle–Ottawa Scale, assigning up to
9 points for selection and comparability of cohorts and
assessment of outcome17. Studies with a score of less than
6 were excluded. The final article selection was confirmed
independently by two authors.
Data extraction
Data including study characteristics, patient characteris-
tics, definitions of anaemia, patient outcomes and statistical
adjustment were extracted using a standard form (Fig. S1,
supporting information) and then entered into a database
(Excel® 2007; Microsoft, Redmond, Washington, USA).
Study authors were contacted where required data were not
reported.
Clinical outcomes
The primary outcome measure was a composite of death
within 30 days of surgery or death before hospital dis-
charge. Secondary outcomes were the incidence of acute
kidney injury, stroke and myocardial infarction within
30 days of surgery, using the authors’ definitions.
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Records identified through
database searching
n = 8694
Additional records identified
through other sources
n = 279
Records after duplicates removed
n = 6509
Full-text articles excluded n = 78
 Not 30-day outcomes/outcomes of interest n = 23
 Not specifically investigating anaemia n = 15
 Not preoperative anaemia n = 11
 Full data not available n = 10
 No comparison group n = 7
 Newcastle–Ottawa Scale <6 n = 6
 Composite outcome reported n = 3
 Trauma population n = 1
 Duplication of data n = 1
 Article retracted n = 1
Records screened
n = 6509
Studies included
n = 24
Records excluded
n = 6407
Full-text articles assessed
for eligibility
n = 102
Fig. 1 PRISMA flow diagram of article selection
Statistical analysis
All statistical analyses were undertaken using Review
Manager version 5.3 (The Cochrane Collaboration,
The Nordic Cochrane Centre, Copenhagen, Denmark).
Studies and their characteristics were first tabulated.
Between-study statistical heterogeneity was assessed by
χ2 and I2 tests, and values of 25, 50 and 75 per cent
were used to indicate the presence of low, moderate and
high between-trial heterogeneity respectively. P< 0⋅100
was considered to denote the statistical significance of
heterogeneity. A funnel plot was constructed for the
primary outcome and assessed visually to establish the
risk of publication bias. For all analyses performed, if no
significant heterogeneity was noted, a fixed-effect model
analysis using the Mantel–Haenszel method was used.
If significant heterogeneity was noted, a random-effects
model analysis using the DerSimonian–Laird method was
employed. Predefined subgroup analyses were undertaken
to explore the effect of anaemia in patients undergoing
cardiac and non-cardiac surgery. A sensitivity analysis
using a random-effects model was performed including
only studies that had applied the World Health Organi-
zation (WHO) definition of anaemia (less than 12 g/dl
for female and less than 13 g/dl for male patients)18.
A post hoc analysis was undertaken to explore the
relationship between anaemia and postoperative infec-
tion. Forest plots were then created to summarize the
models. Findings are presented as odds ratios (ORs) with
95 per cent c.i.
Results
Study selection
A total of 8694 records were identified from the electronic
search strategy, with a further 275 records through grey
literature searches, and four records by hand search. After
removal of duplicates, 6509 records remained. The full
texts of manuscripts reporting 102 studies were retrieved,
of which 24 met the inclusion criteria (Fig. 1).
Characteristics of included studies
Characteristics of the included studies are summarized in
Table 25,19–41. A total of 949 445 patients were included,
and all 24 studies reported the primary outcome of 30-day
or in-hospital mortality. Eight articles reported acute kid-
ney injury. Stroke was reported in six studies, and five
reported myocardial infarction (Table S3, supporting infor-
mation). However, stroke and myocardial infarction were
reported as an outcome only in studies of patients under-
going cardiac surgery (Table 2). A haemoglobin definition
was used in 17 studies5,19,20,22–26,28–31,33,37–39,41, a haema-
tocrit definition in six studies27,32,34–36,40, and both defi-
nitions were used in one study21. Definitions of anaemia
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Table 2 Characteristics of included studies
Outcomes reported
Reference
Study
design Surgery
No. with
anaemia
No. without
anaemia
Definition of
anaemia (g/dl)* Mortality AKI Stroke MI
PRBC
transfusion
reported NOS score
5 PC Non-cardiac 11 295 27439 <13 (M) Yes No No No No 9
<12 (F)
19 PC Non-cardiac 3047 4632 <13 (M) Yes No No No Yes 9
<12 (F)
20 DB Cardiac 6143 30 196 <12 Yes Yes Yes No No 9
21 RC Cardiac 185 3126 <11 Yes Yes Yes Yes Yes 6
22 RC Cardiac 42 159 <12 Yes Yes Yes Yes No 8
23 PC Cardiac 320 727 <13 (M) Yes Yes Yes No Yes 7
<12 (F)
24 PC Orthopaedic 185 158 <13 (M) Yes No No No No 6
<12 (F)
25 RC Orthopaedic 2991 12 231 <13 (M) Yes No No No Yes 6
<12 (F)
26 PC Orthopaedic 180 215 <13 (M) Yes No No No Yes 9
<12 (F)
27 DB Vascular 15 272 16 585 <39%† Yes No No No No 9
28 PC Cardiac 1463 1225 <13 (M) Yes No No No Yes 6
<12 (F)
29 RC GI 125 463 <13 (M) Yes No No No No 6
<12 (F)
30 RC GI 197 216 <13 (M) Yes No No No Yes 6
<12 (F)
31 RC Cardiac 210 366 <13 (M) Yes Yes Yes Yes Yes 7
<12 (F)
32 DB Non-cardiac 69 229 158196 <39%†(M) Yes Yes No No Yes 9
<36%†(F)
33 RC Vascular 193 167 <14 (M) Yes No No No No 7
<12 (F)
34 RC‡ Cardiac 401 401 <30%† Yes Yes Yes Yes Yes 7
35 DB‡ Non-cardiac 119 298 119298 <39%†(M) Yes No No No No 9
<36%†(F)
36 DB Spinal 5879 18 594 <38%† Yes No No No Yes 8
37 RC Cardiac 650 3782 <12 Yes No No No Transfused
patients
excluded
7
38 RC Cardiac 351 1385 <13 (M) Yes No No No No 6
<12 (F)
39 RC Orthopaedic 536 726 <13 (M) Yes No No No Yes 6
<12 (F)
40 DB Non-cardiac 132 970 177341 <39%† Yes No No No No 9
41 RC Cardiac 432 223 <13 (M) Yes Yes No Yes Yes 9
<12 (F)
All outcomes are reported at 30 days or in hospital. *Haemoglobin level below which patients were considered anaemic; †haematocrit definition was used
and is presented as a percentage. ‡A propensity-matched cohort was used in this analysis. AKI, acute kidney injury; MI, myocardial infarction; PRBC,
packed red blood cell; NOS, Newcastle–Ottawa Scale; PC, prospective cohort; DB, national or international database retrospective review; RC,
retrospective cohort; GI, gastrointestinal.
ranged from a haemoglobin concentration of 11 to 12 g/dl
or a haematocrit of 30–39 per cent for female patients,
and from 11 to 14 g/dl or 30–39 per cent respectively for
male patients. Eight studies were of multicentre design.
Nine studies (including 855 031 patients) were performed
in the USA, and 11 reported the timing of haemoglobin
measurement, which varied from time of anaesthesia induc-
tion to 6weeks before surgery.
Frequency of anaemia and blood transfusion
In total, 371 594 of the 949 445 patients were anaemic
as defined by the authors of included studies (39⋅1 per
cent). When restricted to the 13 studies reporting the
WHO definition, 21 322 (29⋅9 per cent) of 71 338 patients
were anaemic. Thirteen studies reported the incidence
of allogeneic red cell transfusion (Table 2), which was
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Reference
Mortality
Weight (%) Odds ratio Odds ratioYear
2002 2·02 (0·48, 8·57)1·85 of 180Gruson et al.26
Cladellas et al.22
Wu et al.40
Bell et al.20
Beattie et al.19
Melis et al.30
De Santo et al.23
Shirzad et al.37
Munoz et al.31
Musallam et al.32
Boening et al.21
Vochteloo et al.39
Hung et al.28
Dubljanin-Raspopovic et al.24
Greenky et al.25
Ranucci et al.34
Oshin and Torella33
Saager et al.35
Gupta et al.27
van Straten et al.38
Seicean et al.36
Jung et al.29
Zhang et al.41
Baron et al.5
Total
Heterogeneity: τ2 = 0·24; χ2 = 768·79, 22 d.f., P < 0·001; I2 = 97%
Test for overall effect: Z = 8·88, P < 0·001
3 of 215
10 of 159
3351 of 177341
798 of 30196
24 of 4632
5 of 216
16 of 727
35 of 3782
19 of 366
1240 of 158196
121 of 3126
31 of 726
13 of 1225
12 of 158
21 of 12231
30 of 401
2 of 167
811 of 119298
206 of 16585
38 of 1385
37 of 18594
0 of 463
3 of 223
604 of 27439
9 of 42
8660 of 132970
325 of 6143
76 of 3047
14 of 197
25 of 320
26 of 650
12 of 210
3192 of 69229
44 of 185
30 of 536
45 of 1463
19 of 185
12 of 2991
51 of 401
16 of 193
1288 of 119298
368 of 15272
20 of 351
63 of 5879
0 of 125
22 of 432
656 of 11295
14978 of 371594 7430 of 577851
2·9
5·9
5·8
4·8
2·8
4·1
4·6
3·7
5·9
5·1
4·6
4·2
3·7
3·9
4·8
1·8
5·9
5·8
4·5
5·1
2·3
5·9
100·0
4·06 (1·53, 10·79)
3·62 (3·47, 3·77)
2·06 (1·80, 2·35)
4·91 (3·10, 7·79)
3·23 (1·14, 9·14)
3·77 (1·98, 7·16)
4·46 (2·67, 7·46)
1·11 (0·53, 2·33)
6·12 (5·73, 6·54)
7·75 (5·28, 11·38)
1·33 (0·79, 2·22)
2·96 (1·59, 5·51)
1·39 (0·65, 2·97)
2·34 (1·15, 4·77)
1·80 (1·12, 2·89)
7·46 (1·69, 32·93)
1·59 (1·46, 1·74)
1·96 (1·65, 2·33)
2·14 (1·23, 3·73)
5·43 (3·62, 8·16)
Not estimable
3·93 (1·16, 13·29)
2·74 (2·45, 3·07)
2·90 (2·30, 3·68)
0·01 0·1
Favours anaemia Favours no anaemia
1 10 100
2006
2007
2008
2009
2009
2009
2010
2010
2011
2011
2011
2011
2011
2012
2012
2013
2013
2013
2013
2013
2013
2013
2014
Anaemia No anaemia
Fig. 2 Forest plot showing composite outcome of 30-day or in-hospital mortality after surgery, according to author-defined anaemia.
Sizes of markers indicate weight for each study according to sample size. A Mantel–Haenszel random-effects model was used for
meta-analysis. Odds ratios are shown with 95 per cent c.i.
Reference
Acute kidney injury
Weight (%) Odds ratio Odds ratio
Cladellas et al.22
Bell et al.20
De Santo et al.23
Munoz et al.31
Musallam et al.32
Boening et al.21
Ranucci et al.34
Zhang et al.41
Total
Heterogeneity: τ2 = 0·05; χ2 = 17·72, 7 d.f., P = 0·01; I2 = 60%
Test for overall effect: Z = 10·79, P < 0·001
20 of 159
262 of 30196
16 of 727
4 of 366
675 of 158196
38 of 3126
18 of 401
2 of 223
20 of 42
183 of 6143
20 of 320
6 of 210
1285 of 69229
12 of 185
28 of 401
22 of 432
1576 of 76962 1035 of 193394
7·5
26·9
9·2
3·2
30·9
9·3
10·5
2·5
100·0
6·32 (2·94, 13·59)
3·51 (2·90, 4·25)
2·96 (1·51, 5·80)
2·66 (0·74, 9·54)
4·41 (4·02, 4·85)
5·64 (2·89, 10·98)
1·60 (0·87, 2·94)
5·93 (1·38, 25·45)
3·75 (2·95, 4·76)
0·01 0·1
Favours anaemia Favours no anaemia
1 10 100
Anaemia No anaemia
Fig. 3 Forest plot of acute kidney injury, according to author-defined anaemia. Sizes of markers indicate weight for each study according
to sample size. A Mantel–Haenszel random-effects model was used for meta-analysis. Odds ratios are shown with 95 per cent c.i.
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Reference
Stroke
Weight (%) Odds ratio Odds ratio
Cladellas et al.22
Bell et al.20
De Santo et al.23
Munoz et al.31
Boening et al.21
Ranucci et al.34
Total
Heterogeneity: χ2 = 4·73, 5 d.f., P = 0·45; I2 = 0%
Test for overall effect: Z = 2·61, P = 0·009
5 of 159
481 of 30196
11 of 727
5 of 366
82 of 3126
0 of 401
2 of 42
124 of 6143
9 of 320
0 of 210
5 of 185
4 of 401
144 of 7301 584 of 34975
1·1
87·9
3·6
2·2
4·9
0·3
100·0
1·54 (0·29, 8·23)
1·27 (1·04, 1·55)
1·88 (0·77, 4·59)
0·16 (0·01, 2·84)
1·03 (0·41, 2·58)
9·09 (0·49, 169·40)
1·28 (1·06, 1·55)
0·01 0·1
Favours anaemia Favours no anaemia
1 10 100
Anaemia No anaemia
Fig. 4 Forest plot of stroke, according to author-defined anaemia. Sizes of markers indicate weight for each study according to sample
size. A Mantel–Haenszel fixed-effect model was used for meta-analysis. Odds ratios are shown with 95 per cent c.i.
Reference
Myocardial infarction
Weight (%) Odds ratio Odds ratio
Cladellas et al.22
Munoz et al.31
Boening et al.21
Ranucci et al.34
Zhang et al.41
Total
Heterogeneity: χ2 = 4·60, 4 d.f., P = 0·33; I2 = 13%
Test for overall effect: Z = 0·43, P = 0·67
4 of 159
17 of 366
24 of 3126
12 of 401
2 of 223
2 of 42
16 of 210
1 of 185
6 of 401
5 of 432
30 of 1270 59 of 4275
5·3
38·0
8·9
39·2
8·7
100·0
1·94 (0·34, 10·96)
1·69 (0·84, 3·43)
0·70 (0·09, 5·22)
0·49 (0·18, 1·33)
1·29 (0·25, 6·72)
1·11 (0·68, 1·82)
0·01 0·1
Favours anaemia Favours no anaemia
1 10 100
Anaemia No anaemia
Fig. 5 Forest plot of myocardial infarction, according to author-defined anaemia. Sizes of markers indicate weight for each study
according to sample size. A Mantel–Haenszel fixed-effect model was used for meta-analysis. Odds ratios are shown with 95 per cent c.i.
more frequent amongst anaemic patients (15 804 (18⋅5
per cent) in anaemic groups versus 9539 (4⋅7 per cent) in
non-anaemic groups; OR 5⋅04, 4⋅12 to 6⋅17; I2 = 96 per
cent; P< 0⋅001) (Fig. S2, supporting information). Patients
who received an allogeneic red cell transfusion were
excluded from one study37, and one article reported allo-
geneic red cell transfusion rates only for anaemic patients33.
Statistical adjustment was carried out in all included stud-
ies, but the method used and variables included in models
were too varied to allow separate analysis. The funnel
plot was symmetrical, indicating that publication bias is
unlikely (Fig. S3, supporting information).
Primary outcome
In-hospital or 30-day mortality
Mortality was reported in all included studies, 12 as 30-day
mortality, eight as in-hospital mortality, and in four studies
a composite of both outcomes was presented. A total of
22 408 patients (2⋅4 per cent) died within 30 days after
surgery or before hospital discharge. Anaemic patients
died more frequently (OR 2⋅90, 2⋅30 to 3⋅68; I2 = 97 per
cent; P< 0⋅001) (Fig. 2). Between-study heterogeneity was
high, possibly owing to the very different populations and
definitions used in included studies, and a random-effects
model was therefore used. Fourteen reports, including
890 605 patients, identified anaemia as an independent
risk factor for mortality. Two articles did not report mul-
tivariable adjustment, and eight articles (including 58 184
patients) did not identify anaemia as an independent risk
factor for mortality.
Secondary outcomes
Acute kidney injury
Eight studies including 270 356 patients reported post-
operative acute kidney injury as an outcome measure
(Table S3, supporting information), seven of which were
confined to patients undergoing cardiac surgery (Table 2).
Anaemia was associated with an increased incidence of
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Reference
Infection
Weight (%) Odds ratio Odds ratio
Cladellas et al.22
Bell et al.20
Melis et al.30
De Santo et al.23
Shirzad et al.37
Munoz et al.31
Musallam et al.32
Boening et al.21
Greenky et al.25
Ranucci et al.34
Saager et al.35
Total
Heterogeneity: τ2 = 0·64; χ2 = 1819·28, 10 d.f., P < 0·001; I2 = 99%
Test for overall effect: Z = 2·57, P = 0·01
16 of 159
338 of 30196
49 of 216
12 of 727
47 of 3782
27 of 366
3214 of 158196
206 of 3126
259 of 12231
14 of 401
7194 of 119298
10 of 42
208 of 6143
46 of 197
5 of 320
21 of 650
20 of 210
4592 of 69229
30 of 185
130 of 2991
26 of 401
7337 of 119298
12425 of 199666 11376 of 328698
7·7
10·0
9·3
7·0
9·1
8·8
10·1
9·4
9·9
8·6
10·1
100·0
2·79 (1·16, 6·72)
3·10 (2·60, 3·69)
1·04 (0·66, 1·64)
0·95 (0·33, 2·71)
2·65 (1·58, 4·47)
1·32 (0·72, 2·42)
3·43 (3·27, 3·59)
2·74 (1·81, 4·16)
2·10 (1·69, 2·60)
1·92 (0·99, 3·73)
1·02 (0·99, 1·06)
1·93 (1·17, 3·18)
0·01 0·1
Favours anaemia Favours no anaemia
1 10 100
Anaemia No anaemia
Fig. 6 Forest plot of risk of infection in anaemic versus non-anaemic patients. Sizes of markers indicate weight for each study according
to sample size. A Mantel–Haenszel random-effects model was used for meta-analysis. Odds ratios are shown with 95 per cent c.i.
postoperative acute kidney injury (OR 3⋅75, 2⋅95 to 4⋅76;
I2 = 60 per cent; P< 0⋅001) (Fig. 3). Between-study hetero-
geneity was moderate and a random-effects model was
used.
Stroke
Six studies including 42 276 patients reported postoper-
ative stroke as an outcome measure (Table S3, supporting
information). All of these studies were confined to patients
having cardiac surgery (Table 2). Anaemia was associated
with an increased risk of stroke in these studies (OR 1⋅28,
1⋅06 to 1⋅55; I2 = 0 per cent; P= 0⋅009) (Fig. 4). There was
no between-study heterogeneity and a fixed-effect model
was used.
Myocardial infarction
Five studies including 5545 patients reported postoperative
myocardial infarction as an outcome measure (Table S3,
supporting information). All of these studies were confined
to patients undergoing cardiac surgery (Table 2). There was
no significant difference in the incidence of myocardial
infarction between anaemic and non-anaemic patients (OR
1⋅11, 0⋅68 to 1⋅82; I2 = 13 per cent; P= 0⋅67) (Fig. 5). There
was low between-study heterogeneity and a fixed-effect
model was used.
Subgroup analyses
Non-cardiac surgery
Fourteen studies were identified including 897 658
non-cardiac surgical patients of whom 361 397 (40⋅3 per
cent) were anaemic. These studies described various sur-
gical specialty groups including vascular, orthopaedic,
spinal and upper gastrointestinal surgery. Anaemia was
associated with an increased risk of death in non-cardiac
surgical patients (OR 2⋅87, 2⋅10 to 3⋅93; I2 = 98 per cent;
P< 0⋅001) (Fig. S4, supporting information). There was
high between-study heterogeneity and a random-effects
model was used.
Cardiac surgery
Ten studies were identified including 51 787 cardiac surgi-
cal patients, of whom 10 197 (19⋅7 per cent) were anaemic.
Anaemia was associated with an increased risk of death
for patients undergoing cardiac surgery (OR 2⋅98, 2⋅02
to 4⋅38; I2 = 84 per cent; P< 0⋅001) (Fig. S4, supporting
information).
Sensitivity analysis
World Health Organization definition of anaemia
The WHO definition of anaemia was employed in 13
studies including 71 338 patients, of whom 21 332 (29⋅9
per cent) were anaemic. When the analysis was restricted
to these studies, the association between anaemia and
postoperative mortality remained (OR 2⋅46, 1⋅91 to
3⋅17; I2 = 56 per cent; P< 0⋅001) (Fig. S5, supporting
information). Between-study heterogeneity was moder-
ately reduced, probably because of the uniform definitions
dividing the study populations, and a random-effects model
was used.
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Post hoc analysis
Postoperative infection
During review of the literature, 11 studies were identified
that included data describing postoperative infection,
seven in the setting of cardiac surgery and four in
non-cardiac surgery. An additional post hoc analysis
using a random-effects model to evaluate the relation-
ship between preoperative anaemia and postoperative
infection was therefore performed. Some 23 801 (4⋅5 per
cent) of 528 364 patients developed an infection after
surgery. Anaemia was associated with an increased inci-
dence of infection (OR 1⋅93, 1⋅17 to 3⋅18; I2 = 99 per
cent; P= 0⋅01) (Fig. 6). There was high between-study
heterogeneity, probably owing to the variety of included
infections, and a random-effects model was used.
Discussion
The principal finding of this analysis is that preoperative
anaemia is associated with increased short-term mortality
after surgery. This association was also present when car-
diac and non-cardiac surgery subgroups were analysed sep-
arately, and in studies that employed the WHO definition
of anaemia. Preoperative anaemia is also associated with
an increased risk of acute kidney injury and infection after
surgery. Amongst cardiac surgical patients, preoperative
anaemia is associated with stroke but notmyocardial infarc-
tion, perhaps reflecting improved coronary artery perfu-
sion after surgery. These observations do not confirm a
causal relationship, but it is important to note that the diag-
nosis of anaemia appears to alter clinical practice because
allogeneic red cell transfusion is more frequent amongst
anaemic patients. Statistical heterogeneity was very high
for a number of analyses, probably owing to the very differ-
ent populations and definitions of anaemia used in included
studies. Caution is therefore required in interpretation of
these findings.
The findings of this systematic review of 24 studies are
consistent with those of the component studies, which
either suggest that preoperative anaemia is associated with
adverse outcomes following surgery, or show no difference
in these outcomes. The present findings are also consis-
tent with reports in other patient groups suggesting that
anaemia is associated with poor outcome8,9. It is interest-
ing to note that the association between anaemia and mor-
tality was stronger than that with morbidity. This partly
reflects the fact that fewer reports provide data describing
morbidity outcomes, butmay also be explained by inconsis-
tent reporting of complications within and between studies,
and the high levels of heterogeneity associated with the
presentmortality findings. The stroke outcome data should
be interpreted with caution as 86⋅0 per cent of patients in
this analysis were contributed by a single study20 of patients
undergoing coronary artery bypass.
The absence of any association between myocardial
infarction and anaemia is surprising, given first principles
of physiology regarding the balance of myocardial oxy-
gen supply and demand. This may relate to the fact that
myocardial infarction was reported as a separate outcome
in only a few studies contributing 5545 cardiac surgical
patients, compared with 42 276 patients with data describ-
ing the outcome of stroke and 270 356 describing acute
kidney injury.
Perhaps unsurprisingly, allogeneic red cell transfusion
occurred at a higher rate amongst anaemic than non-
anaemic patients. Both anaemia and its treatment by
allogeneic red cell transfusion have been associated with
increased mortality and morbidity, and it remains unclear
whether correcting preoperative anaemia can improve
outcomes14. Investigators are exploring the value of various
preoperative treatments for anaemia, including intravenous
iron and erythropoietin. However, the evidence base for
this area of clinical practice remains limited. Other aspects
of patient blood management, such as minimizing peri-
operative blood loss through the use of tranexamic acid,
are also being explored42. Anaemic patients are more
likely to develop an infection following surgery, perhaps
reflecting the immunosuppressant effects of allogeneic
red cell transfusion, as well as the increased incidence of
co-morbid disease in the anaemic population43.
The present findings emphasize the importance of
anaemia and PBM, which has been promoted by the
WHO, with initiatives under way in many countries. In
the UK, the National Health Service has issued guidance
for this area of practice, and a formal National Institute
for Health and Care Excellence guideline is currently
in draft. It was not possible to account for the potential
confounding effect of co-morbid disease, and it remains
unclear whether anaemia is the cause of poor outcome
after surgery or a marker of increased risk. The data
sets available to many of the included studies probably
included only those patients who required preoperative
haemoglobin estimation. Some element of reporting bias
seems likely, and the proportion of anaemic patients may
be overestimated.
The strength of this study is that it was conducted accord-
ing to a robust, prospectively written and published analysis
plan by a multidisciplinary group, with experience in
meta-analyses in perioperative medicine and haematology.
Studies were assessed rigorously for methodological qual-
ity, and only those of sufficient quality were included in the
analysis. However, this analysis has a number of limitations,
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the principal one being the high level of statistical and clin-
ical heterogeneity in the findings. This heterogeneity likely
exists because of the variety of populations studied and the
different definitions used by included studies. Preopera-
tive timing of haemoglobin or haematocrit reporting was
reported infrequently, preventing any adjustment for this
source of bias. A number of studies reported haematocrit,
creating additional heterogeneity in the available data. It
is also possible that all eligible papers were not located by
the electronic search strategy. It was not possible to adjust
for the effect of allogeneic red cell transfusion, owing to
the largely unavailable data describing the number of red
cell transfusions received per patient. This limited the
ability to determine the independent effect of anaemia
on outcome. Where risk adjustment was reported, the
technique used varied widely. Unmeasured confounding
and selection bias are often present in observational stud-
ies, and it remains possible that the use of observational
data with such bias may produce spurious results with
an apparently high degree of precision44. The high level
of between-study heterogeneity observed may place the
present analysis at risk of this. Moreover, cardiac surgery
is over-represented within this cohort. The majority of
component studies were single-centre in design, and five
component studies were derived from the same database
(National Surgical Quality Improvement Project, USA).
This may have resulted in overlap of included patients;
however, a sensitivity analysis was performed excluding all
but the largest of these studies, and the findings remained
unchanged40.
Preoperative anaemia is associated with increased
short-term mortality after surgery, as well as an increased
incidence of stroke, acute kidney injury and infection.
These results should be interpreted with care given the
high levels of heterogeneity between studies. Although
these observations will, at least partially, reflect the severity
of co-morbid disease among included patients, allogeneic
red cell transfusion is also more common in the presence
of anaemia. The current evidence base for allogeneic red
cell transfusion in surgical patients is limited. There is,
therefore, a need for large, well designed, randomized tri-
als with a low risk of bias to confirm the optimal strategies
for the treatment of anaemia in the perioperative period.
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Editor’s comments
In this issue of BJS a couple of papers focus on bleeding and anaemia. Patient blood management (PBM) reviewed by
Clevenger et al. (Br J Surg 2015; 102: 1325–1337) is a collection of strategies to improve blood transfusion practices
that is adopted by the WHO and spreading across Europe. There is increasing evidence that implementation of PBM
is associated with improved clinical outcomes, and the principles of PBM can be used to address anaemia, blood loss
and transfusion in the surgical setting.
In this meta-analysis by Fowler et al. preoperative anaemia is associated with short-term mortality after surgery
and an increased incidence of stroke, acute kidney injury and infection. Allogeneic red cell transfusion was unsur-
prisingly more common in the presence of anaemia. Although the observed preoperative anaemia is partly related to
co-morbidity in the surgical patient, one cannot help wondering whether the outcome could be improved by leaning
on the PBM pillars?
Primum non nocere as stated in the Hippocratic oath should be adhered to when considering anaemia and transfusion
in the surgical patient, instead of a knee-jerk reaction to treat a haemoglobin level on the laboratory chart.
M. Sund
Editor, BJS
© 2015 BJS Society Ltd www.bjs.co.uk BJS 2015; 102: 1314–1324
Published by John Wiley & Sons Ltd
